Stockreport

Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share [Yahoo! Finance]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF The offer is supported by Revance's Board of Directors, who recommend that stockholders tender their shares. The tender offer is scheduled to expire on January 13, 2025, [Read more]